13F HOLDINGS REPORT
BROADWOOD CAPITAL INC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0000919574-24-006537
Total Value
$1.30B
Positions
7
Other Managers
1
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MONSTER BEVERAGE CORP NEW | MNST | 8,295,690 | $432.8M | 33.20% |
| 2 | STAAR SURGICAL CO | STAA | 10,768,431 | $400.0M | 30.68% |
| 3 | AXON ENTERPRISE INC | AXON | 760,062 | $303.7M | 23.30% |
| 4 | ISHARES TR | 464287655 | 519,920 | $114.8M | 8.81% |
| 5 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 41,666,255 | $37.7M | 2.89% |
| 6 | ONCOCYTE CORP | IMDX | 4,929,066 | $14.0M | 1.08% |
| 7 | SERINA THERAPEUTICS INC | SER | 85,219 | $570,115 | 0.04% |